Tactile Systems Technology, Inc. Current Federal Tax Expense (Benefit)
Tactile Systems Technology, Inc. (TCMD) reported Current Federal Tax Expense (Benefit) of $2.29 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-17
- Tactile Systems Technology, Inc. current federal tax expense (benefit) for fiscal 2025 was $2.29M, a 46.79% decline from fiscal 2024.
- Tactile Systems Technology, Inc. current federal tax expense (benefit) for fiscal 2024 was $4.30M, a 14.69% decline from fiscal 2023.
- Tactile Systems Technology, Inc. current federal tax expense (benefit) for fiscal 2023 was $5.04M, a 174.48% increase from fiscal 2022.
- Tactile Systems Technology, Inc. current federal tax expense (benefit) for fiscal 2022 was $1.84M.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $2.29M 10-K · filed 2026-02-17 |
| 2024-12-31 | $4.30M 10-K · filed 2026-02-17 |
| 2023-12-31 | $5.04M 10-K · filed 2026-02-17 |
| 2022-12-31 | $1.84M 10-K · filed 2025-02-18 |
| 2021-12-31 | -$1.27M 10-K · filed 2024-02-20 |
| 2020-12-31 | -$653.00K 10-K · filed 2023-02-21 |
| 2019-12-31 | $205.00K 10-K · filed 2022-02-23 |
| 2018-12-31 | $2.42M 10-K · filed 2021-02-23 |
| 2017-12-31 | -$2.28M 10-K · filed 2020-02-26 |
| 2016-12-31 | $1.81M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |